Annual Accounts Payable
$1.19 M
-$530.00 K-30.81%
December 31, 2023
Summary
- As of February 8, 2025, ALRN annual accounts payable is $1.19 million, with the most recent change of -$530.00 thousand (-30.81%) on December 31, 2023.
- During the last 3 years, ALRN annual accounts payable has fallen by -$406.00 thousand (-25.44%).
- ALRN annual accounts payable is now -39.62% below its all-time high of $1.97 million, reached on December 31, 2016.
Performance
ALRN Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.08 M
+$297.00 K+37.98%
September 30, 2024
Summary
- As of February 8, 2025, ALRN quarterly accounts payable is $1.08 million, with the most recent change of +$297.00 thousand (+37.98%) on September 30, 2024.
- Over the past year, ALRN quarterly accounts payable has increased by +$595.00 thousand (+122.93%).
- ALRN quarterly accounts payable is now -63.96% below its all-time high of $2.99 million, reached on September 30, 2018.
Performance
ALRN Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ALRN Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.8% | +122.9% |
| 3 y3 years | -25.4% | -37.3% |
| 5 y5 years | -31.3% | -37.3% |
ALRN Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.8% | at low | -50.0% | +693.4% |
| 5 y | 5-year | -30.8% | at low | -50.0% | +693.4% |
| alltime | all time | -39.6% | +85.7% | -64.0% | +693.4% |
Aileron Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.08 M(+38.0%) |
| Jun 2024 | - | $782.00 K(-63.7%) |
| Mar 2024 | - | $2.16 M(+81.2%) |
| Dec 2023 | $1.19 M(-30.8%) | $1.19 M(+145.9%) |
| Sep 2023 | - | $484.00 K(+255.9%) |
| Jun 2023 | - | $136.00 K(-70.3%) |
| Mar 2023 | - | $458.00 K(-73.4%) |
| Dec 2022 | $1.72 M(+42.1%) | $1.72 M(+82.0%) |
| Sep 2022 | - | $945.00 K(-45.7%) |
| Jun 2022 | - | $1.74 M(+70.2%) |
| Mar 2022 | - | $1.02 M(-15.5%) |
| Dec 2021 | $1.21 M(-24.2%) | $1.21 M(+16.9%) |
| Sep 2021 | - | $1.03 M(+1.9%) |
| Jun 2021 | - | $1.02 M(+81.4%) |
| Mar 2021 | - | $560.00 K(-64.9%) |
| Dec 2020 | $1.60 M | $1.60 M(+59.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $1.00 M(+0.9%) |
| Jun 2020 | - | $993.00 K(-8.7%) |
| Mar 2020 | - | $1.09 M(-25.1%) |
| Dec 2019 | $1.45 M(-16.1%) | $1.45 M(-38.2%) |
| Sep 2019 | - | $2.35 M(+36.6%) |
| Jun 2019 | - | $1.72 M(+100.3%) |
| Mar 2019 | - | $858.00 K(-50.4%) |
| Dec 2018 | $1.73 M(+8.2%) | $1.73 M(-42.2%) |
| Sep 2018 | - | $2.99 M(+89.1%) |
| Jun 2018 | - | $1.58 M(-11.9%) |
| Mar 2018 | - | $1.80 M(+12.3%) |
| Dec 2017 | $1.60 M(-18.8%) | $1.60 M(-3.0%) |
| Sep 2017 | - | $1.65 M(-25.4%) |
| Jun 2017 | - | $2.21 M(+113.7%) |
| Mar 2017 | - | $1.03 M(-47.5%) |
| Dec 2016 | $1.97 M(+207.5%) | $1.97 M |
| Dec 2015 | $641.00 K | - |
FAQ
- What is Aileron Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Aileron Therapeutics?
- What is Aileron Therapeutics annual accounts payable year-on-year change?
- What is Aileron Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Aileron Therapeutics?
- What is Aileron Therapeutics quarterly accounts payable year-on-year change?
What is Aileron Therapeutics annual accounts payable?
The current annual accounts payable of ALRN is $1.19 M
What is the all time high annual accounts payable for Aileron Therapeutics?
Aileron Therapeutics all-time high annual accounts payable is $1.97 M
What is Aileron Therapeutics annual accounts payable year-on-year change?
Over the past year, ALRN annual accounts payable has changed by -$530.00 K (-30.81%)
What is Aileron Therapeutics quarterly accounts payable?
The current quarterly accounts payable of ALRN is $1.08 M
What is the all time high quarterly accounts payable for Aileron Therapeutics?
Aileron Therapeutics all-time high quarterly accounts payable is $2.99 M
What is Aileron Therapeutics quarterly accounts payable year-on-year change?
Over the past year, ALRN quarterly accounts payable has changed by +$595.00 K (+122.93%)